Real-world experience of the feasibility and tolerability of the 2:1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia

Megan Crumbaker, Howard Gurney, Alex Guminski, Shirley Wong, Dhanusha Sabanathan, Nick Pavlakis

Research output: Contribution to journalMeeting abstractResearch

LanguageEnglish
Article numberabs#209
Pages47
Number of pages1
JournalAsia-Pacific Journal of Clinical Oncology
Volume12
Issue numberS3
DOIs
Publication statusPublished - Jul 2016
EventANZUP Annual Scientific Meeting: Expanding our Horizons - Brisbane, Australia
Duration: 10 Jul 201612 Jul 2016

Cite this

@article{1f4de5060f5d453586181d06468666cd,
title = "Real-world experience of the feasibility and tolerability of the 2:1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia",
author = "Megan Crumbaker and Howard Gurney and Alex Guminski and Shirley Wong and Dhanusha Sabanathan and Nick Pavlakis",
year = "2016",
month = "7",
doi = "10.1111/ajco.12559",
language = "English",
volume = "12",
pages = "47",
journal = "Asia-Pacific Journal of Clinical Oncology",
issn = "1743-7555",
publisher = "Wiley-Blackwell, Wiley",
number = "S3",

}

Real-world experience of the feasibility and tolerability of the 2:1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia. / Crumbaker, Megan; Gurney, Howard; Guminski, Alex; Wong, Shirley; Sabanathan, Dhanusha; Pavlakis, Nick.

In: Asia-Pacific Journal of Clinical Oncology, Vol. 12, No. S3, abs#209, 07.2016, p. 47.

Research output: Contribution to journalMeeting abstractResearch

TY - JOUR

T1 - Real-world experience of the feasibility and tolerability of the 2:1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia

AU - Crumbaker, Megan

AU - Gurney, Howard

AU - Guminski, Alex

AU - Wong, Shirley

AU - Sabanathan, Dhanusha

AU - Pavlakis, Nick

PY - 2016/7

Y1 - 2016/7

U2 - 10.1111/ajco.12559

DO - 10.1111/ajco.12559

M3 - Meeting abstract

VL - 12

SP - 47

JO - Asia-Pacific Journal of Clinical Oncology

T2 - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

SN - 1743-7555

IS - S3

M1 - abs#209

ER -